PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

Quality Control and Regulatory Aspects for Biologicals

Regulations and Best Practices

Gauri Misra

$187

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
CRC Press
22 April 2024
This book serves as a comprehensive guide on quality control and regulatory aspects for biological products. It covers a wide range of topics, including regulatory requirements, quality control strategies, analytical methods, and risk management. It delves into the advantages and limitations of in vivo tests and discusses alternative methods that can be employed. The book explores the use of animal-based testing methods in quality control and examines viable alternatives.

Key Features:

Reviews various scientific and regulatory aspects involved in the quality control of biologicals Provides an overview of the roles of various national and international regulatory bodies and accreditation agencies Presents advanced analytical methods, innovative technologies, and the integration of molecular diagnostics in quality control processes Explores the use of animal-based testing methods in quality control, as well as their alternatives Discusses guidelines and methodologies involved in the development of biological products

Overall, this book is an important reference source for various professionals in the pharmaceutical industry, including researchers, scientists, quality control personnel, and regulatory affairs professionals.

Edited by:  
Imprint:   CRC Press
Country of Publication:   United Kingdom
Dimensions:   Height: 229mm,  Width: 152mm, 
Weight:   1.180kg
ISBN:   9781032697406
ISBN 10:   1032697407
Pages:   184
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

Dr Gauri Misra is working as a scientist and the Head of the Molecular Diagnostics and COVID-19 Kit Testing Laboratory at the National Institute of Biologicals (Ministry of Health and Family Welfare), Noida. She is significantly contributing towards quality control regulation of biologicals, ensuring the release of only quality biologicals in the Indian market, thus safeguarding public health and promoting access to good quality biological products and healthcare. She has extensive experience in the field of molecular diagnostics and cancer biology. She has completed her doctorate from the Central Drug Research Institute, Lucknow and postdoctoral studies at the CHUL Research Centre, Quebec. She has been the recipient of many awards at different stages of her career. She has published more than 30 research articles in highly reputed, peer-reviewed journals, five international books, and six chapters. She has been invited as a speaker at various national and international institutes.

See Also